PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF REPLACING PCV13 WITH PCV15 IN THE NATIONAL IMMUNIZATION PROGRAM IN SAUDI ARABIA

被引：0
|
作者：
Huang, M. [1 ]
Weaver, J. [2 ]
Albassam, G. [3 ]
Akel, R. [4 ]
Chhabra, N. [5 ]
Ranjan, S. [5 ]
Gupta, S. [6 ]
Ugrekhelidze, D. [7 ]
机构：
[1] Merck & Co Inc, Merck Res Labs, Rahway, NJ USA
[2] Merck & Co Inc, Rahway, NJ USA
[3] MSD, Riyadh, Saudi Arabia
[4] MSD, Dubai, U Arab Emirates
[5] CHEORS, North Wales, PA USA
[6] CHEORS, Patna, BR, India
[7] MSD, Zurich, Switzerland
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE562
引用
收藏
页数：2
相关论文
共 50 条
  • [41] THE COST-EFFECTIVENESS ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE (PPV23) IN TAIWAN
    Wu, D. B. C.
    Chang, C. J.
    Chien, L.
    Fang, H. C. H.
    Roberts, C. S.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A602
  • [42] HEALTH IMPACT AND COST-EFFECTIVENESS OF IMPLEMENTING HUMAN PAPILLOMAVIRUS (HPV) VACCINE TO NATIONAL IMMUNIZATION PROGRAM (NIP) IN THAILAND
    Termrungruanglert, W.
    Khemapech, N.
    Havanond, P.
    Pillsbury, M.
    Shcheprov, A.
    Numuang, K.
    Metharom, E.
    Kulkarni, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 662 - 662
  • [43] PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN PUBLIC AND PRIVATE SYSTEM VERSUS PPSV23 AND NO VACCINATION IN OLDER ADULTS
    Ferreira, C. N.
    Santana, C. F.
    Rufino, C.
    VALUE IN HEALTH, 2015, 18 (07) : A839 - A839
  • [44] COST-EFFECTIVENESS ANALYSIS OF THE NEW PCV-13 VACCINE WHEN COMPARED TO NO VACCINATION FROM A PUBLIC HEALTH-CARE SYSTEM PERSPECTIVE IN HONG KONG
    Lee, K. K.
    Chow, D. P.
    VALUE IN HEALTH, 2010, 13 (07) : A549 - A549
  • [45] Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan
    Igarashi, Ataru
    Hirose, Emi
    Kobayashi, Yasuhiro
    Yonemoto, Naohiro
    Lee, Bennett
    EXPERT REVIEW OF VACCINES, 2021, 20 (09) : 1153 - 1165
  • [46] Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study
    Candeias, Catarina
    Almeida, Sonia T.
    Paulo, A. Cristina
    Simoes, Alexandra S.
    Ferreira, Barbara
    Cruz, Ana R.
    Queiros, Miguel
    Touret, Tiago
    Brito-Avo, Antonio
    de Lencastre, Herminia
    Sa-Leao, Raquel
    VACCINE, 2024, 42 (22)
  • [47] Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs
    Wang, Jiahao
    Zhang, Haijun
    Zhang, Haonan
    Fang, Hai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (07)
  • [48] Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China
    Shen, Kunling
    Wasserman, Matthew
    Liu, Dongdong
    Yang, Yong-Hong
    Yang, Junfeng
    Guzauskas, Greg F.
    Wang, Bruce C. M.
    Hilton, Betsy
    Farkouh, Raymond
    PLOS ONE, 2018, 13 (07):
  • [49] Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme (vol 97, pg 182, 2020)
    Farinas, Anai Garcia
    Linares-Perez, Nivaldo
    Clark, Andrew
    Toledo-Romani, Maria Eugenia
    El Omeiri, Nathalie
    Araujo, Martha C. Marrero
    Luis, Isabel Pilar Gonzalvez
    Peraza, Gilda Torano
    Jimenez, Alicia Reyes
    Ambron, Lena Lopez
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 : 643 - 643
  • [50] COST EFFECTIVENESS ANALYSIS OF VACCINATION WITH 13-VALENT (PCV13) AND 23-VALENT (PPV23) PNEUMOCOCCAL VACCINES FOR SENIOR ADULTS IN SAO PAULO STATE, BRAZIL - PUBLIC PERSPECTIVE
    Fujii, R. K.
    Roberts, C. S.
    Mould, J.
    Presa, J.
    Jardim, E.
    Manfrin, D. F.
    VALUE IN HEALTH, 2012, 15 (07) : A397 - A397
12345